Trial Profile
A study evaluating effect of antacids on doravirine pharmacokinetics.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2019
Price :
$35
*
At a glance
- Drugs Doravirine (Primary) ; Pantoprazole; Simethicone/aluminium hydroxide/magnesium oxide
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 28 Feb 2019 Results evaluating Doravirine Pharmacokinetics When Coadministered With Acid-Reducing Agents published in the Journal of Clinical Pharmacology
- 31 Aug 2017 New trial record
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science